Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
A report from the U.S. FDA's Office of Inspector General ... The report looked at 24 drugs that went through the accelerated approval process. It said that for 21 of them, "there was a consistent ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...